Private Equity Transactions in Healthcare: Stark, AKS and Other Compliance Challenges
Structuring Purchase Price, Restrictive Covenants, Indemnities, Equity Rollovers and More
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will guide counsel involved in structuring private equity transactions in the healthcare arena. The panel will discuss the nuts and bolts of structuring the transaction, including purchase price considerations, tax structures, deal terms and indemnities. The panel will also address approaches to overcome regulatory problems.
- Purchase price considerations
- Deal and tax structuring and the impact of legacy tax structures and the corporate practice of medicine
- Common deal terms and indemnities
- Regulatory issues
- Restrictive covenants
- Equity rollover considerations and structuring of governance, puts/calls, and tag-along/drag-along considerations
The panel will review these and other noteworthy issues:
- What hurdles do counsel encounter when involving private equity firms in healthcare transactions?
- What factors should counsel keep in mind when determining price and deal structure?
- What best practices should counsel employ to ensure regulatory compliance in a healthcare private equity transaction?
John C. Riddle
Brown Gibbons Lang & Company
Mr. Riddle leads the firm's investment banking activities in Healthcare and Life Sciences. He has over twenty years... | Read More
Mr. Riddle leads the firm's investment banking activities in Healthcare and Life Sciences. He has over twenty years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic advisory assignments.Close
Roger D. Strode
Foley & Lardner
Mr. Strode's practice focuses on health care business transactions, including mergers, acquisitions, corporate... | Read More
Mr. Strode's practice focuses on health care business transactions, including mergers, acquisitions, corporate restructurings and joint ventures, general corporate matters and health care regulation. His experience includes the representation of institutional health care providers, large physician groups, specialty providers (ASC development organizations), health care private equity firms and industry consultants. He participated as lead counsel in numerous health care and corporate transactions, including the purchase and sale, or transfer of sponsorship of hospitals, health systems, physician practices and health maintenance organizations; the formation of specialty hospitals; and the formation of ancillary services joint ventures.Close